Related Experiment Video

Updated: Jul 12, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

New HIV drugs show promise in early studies

Michael McCarthy

    Lancet (London, England)
    |March 13, 2002
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
    11:34

    High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

    Published on: May 5, 2014

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
    09:29

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

    Published on: October 29, 2015

    Related Experiment Videos

    Last Updated: Jul 12, 2026

    Assays for the Identification of Novel Antivirals against Bluetongue Virus
    12:02

    Assays for the Identification of Novel Antivirals against Bluetongue Virus

    Published on: October 11, 2013

    High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
    11:34

    High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

    Published on: May 5, 2014

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
    09:29

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

    Published on: October 29, 2015

    Related Concept Videos

    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

    Articles linked to this work by shared authors, journal, and citation graph.

    Registered report: transcriptional amplification in tumor cells with elevated c-Myc.

    eLife·2015

    Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.

    Oncotarget·2015

    Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

    Lancet (London, England)·2026

    Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

    Lancet (London, England)·2026

    Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

    Lancet (London, England)·2026

    The changing therapeutic landscape of small-cell lung cancer.

    Lancet (London, England)·2026

    Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.

    Lancet (London, England)·2026

    Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study.

    Lancet (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us